secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2022-05-26T23:59:59+00:00
Accession:  0001171520-22-000351
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro stockholders approve authorized share reduction from 200M to 80M
--------------------------------------------------------------------------------

- Authorized common shares reduced from 200M to 80M via Certificate of Amendment.
- Eight directors elected, including Joseph Burnett, R. John Fletcher, and Matthew Klein.
- Cherry Bekaert LLP ratified as independent auditor for FY 2022; 15.8M for, 19.6K against.
- Fourth Amended and Restated 2013 Incentive Compensation Plan approved (8.7M for).
- Advisory vote on executive compensation approved with 8.6M for, 887K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/0001171520-22-000351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000117152022000351/eps10282.htm
  HTML page:      https://secwatch.observer/filing/0001171520-22-000351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer